Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 3
Submit an article Journal homepage
1,514
Views
56
CrossRef citations to date
0
Altmetric
Review Article

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

Arjan A. van de LoosdrechtDepartment of Hematology, VU University Medical Center, Amsterdam, The NetherlandsCorrespondence[email protected]
,
Robin IrelandKing's College Hospital, London, UK
,
Wolfgang KernMLL Munich Leukemia Laboratory, Munich, Germany
,
Matteo G. Della PortaDepartment of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia and University of Pavia, Italy
,
Canan AlhanDepartment of Hematology, VU University Medical Center, Amsterdam, The Netherlands
,
Jan Sebastian BalleisenDepartment of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
,
Peter BettelheimFirst Medical Department, Elisabethinen Hospital, Linz, Austria
,
David T. BowenHMDS, St. James's University Hospital, Leeds, UK
,
Kate BurburyDepartment of Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
,
Lisa EidenschinkHematoLogics, Inc., Seattle, WA, USA
,
Mario CazzolaDepartment of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia and University of Pavia, Italy
,
Spencer S. C. ChuDepartment of Oncology/Hematology, Buddhist Tzu Chi General Hospital, Institute of Medical Sciences, College of Medicine, Department of Medicine, Tzu-Chi University, Hualien, Taiwan
,
Matthew CullenHMDS, St. James's University Hospital, Leeds, UK
,
Jevon A. CutlerHematoLogics, Inc., Seattle, WA, USA
,
Angelika M. DrägerDepartment of Hematology, VU University Medical Center, Amsterdam, The Netherlands
,
Jean FeuillardLaboratoire d’Hématologie, CHU Dupuytren, Limoges, France
,
Pierre FenauxHôpital Avicenne (Assistance Publique-Hôpitaux de Paris), Bobigny, France
,
Patricia FontDepartment of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Ulrich GermingDepartment of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
,
Detlef HaaseDepartment of Hematology and Oncology, Georg-August-University, Göttingen, Germany
,
Eva Hellström-LindbergDepartment of Pathology, Karolinska University Hospital, Stockholm, Sweden
,
Ulrika JohanssonDepartment of Haematology, University Hospitals NHS Foundation Trust, Bristol, UK
,
Shahram KordastiKing's College Hospital, London, UK
,
Michael R. LokenHematoLogics, Inc., Seattle, WA, USA
,
Luca MalcovatiDepartment of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia and University of Pavia, Italy
,
Jeroen G. te MarveldeDepartment of Immunology, Erasmus MC, Rotterdam, The Netherlands
,
Sergio MatarrazServicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer (CSIC/USAL) and Department of Medicine, Universidad de Salamanca, Spain
,
Timothy MilneKing's College Hospital, London, UK
,
Bijan MoshaverDepartment of Hematology, St Radboud University Medical Center, Nijmegen, The Netherlands
,
Ghulam J. MuftiKing's College Hospital, London, UK
,
Veselka NikolovaNational Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria
,
Kiyoyuki OgataDivision of Hematology, Department of Medicine, Nippon Medical School, Tokyo, Japan
,
Uta OelschlaegelMedizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Germany
,
Alberto OrfaoServicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer (CSIC/USAL) and Department of Medicine, Universidad de Salamanca, Spain
,
Gert J. OssenkoppeleDepartment of Hematology, VU University Medical Center, Amsterdam, The Netherlands
,
Anna PorwitDepartment of Pathology, Karolinska University Hospital, Stockholm, Sweden
,
Uwe PlatzbeckerMedizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Germany
,
Frank PreijersDepartment of Hematology, St Radboud University Medical Center, Nijmegen, The Netherlands
,
Katherina PsarraDeptartment of Immunology – Histocompatibility, Evangelismos Hospital, Athens, Greece
,
Stephen J. RichardsHMDS, St. James's University Hospital, Leeds, UK
,
Dolores SubiráDepartment of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain
,
John F. SeymourDepartment of Haematology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia
,
Vicky TindellKing's College Hospital, London, UK
,
Teresa VallespiDepartment of Hematology, Hospital Universitario, Valld’Hebron, Barcelona, Spain
,
Peter ValentDepartment of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
,
Vincent H. J. van der VeldenDepartment of Immunology, Erasmus MC, Rotterdam, The Netherlands
,
Denise A. WellsHematoLogics, Inc., Seattle, WA, USA
,
Theo M. de WitteDepartment of Hematology, St Radboud University Medical Center, Nijmegen, The Netherlands
,
Florian ZettlDepartment of Hematology and Oncology, Georg-August-University, Göttingen, Germany
,
Marie C. BénéFaculty of Medicine and CHU, Nancy Université, France
&
Theresia M. WestersDepartment of Hematology, VU University Medical Center, Amsterdam, The Netherlands
 show all
Pages 472-475 | Received 27 Apr 2012, Accepted 09 Jun 2012, Published online: 14 Sep 2012
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.